Search Results

Understanding Autophagy in Cell Death Control

Authors: Platini, Francesca; Perez-Tomas, Ricardo; Ambrosio, Santiago; Tessitore, Luciana

Source: Current Pharmaceutical Design, Volume 16, Number 1, January 2010 , pp. 101-113(13)

Publisher: Bentham Science Publishers

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

Authors: Giovannetti, Elisa; Honeywell, Richard; Hanauske, Axel R.; Tekle, Christina; Kuenen, Bart; Sigmond, Jennifer; Giaccone, Giuseppe; Peters, Godefridus J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 12-28(17)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action

Authors: Joerger, M.; Omlin, A.; Cerny, T.; Fruh, M.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 37-47(11)

Publisher: Bentham Science Publishers

Prioritization of cancer antigens: keeping the target in sight

Authors: Lang, Joshua M; Andrei, Adin-Cristian; McNeel, Douglas G

Source: Expert Review of Vaccines, Volume 8, Number 12, December 2009 , pp. 1657-1661(5)

Publisher: Expert Reviews

ABCG2: the key to chemoresistance in cancer stem cells?

Authors: An, Yi; Ongkeko, Weg M

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 12, December 2009 , pp. 1529-1542(14)

Publisher: Informa Healthcare

Synthesis and Crystal Structure of 7,8-Dihydroquinolino[2,3-a]acridine Derivatives

Authors: Han, Guang-Fan; Wang, Rui-Hua; Zhang, Wen-Tao; Zhao, Yu-Yuan; Xing, Zheng; Dai, Wei

Source: Synthetic Communications, Volume 39, Number 14, January 2009 , pp. 2492-2505(14)

Publisher: Taylor and Francis Ltd

Effect of recombinant feline interferon-ω alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours

Authors: Penzo, C.; Ross, M.; Muirhead, R.; Else, R.; Argyle, D. J.

Source: Veterinary and Comparative Oncology, Volume 7, Number 4, December 2009 , pp. 222-229(8)

Publisher: Blackwell Publishing

Overview of the Molecular Bases of Resistance to Chemotherapy in Liver and Gastrointestinal Tumours

Authors: Marin, J. J.G.; Romero, M. R.; Martinez-Becerra, P.; Herraez, E.; Briz, O.

Source: Current Molecular Medicine, Volume 9, Number 9, December 2009 , pp. 1108-1129(22)

Publisher: Bentham Science Publishers

Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting β-catenin signalling

Authors: Bi, Xiuli; Zhao, Yuqing; Fang, Wenfeng; Yang, Wancai

Source: Clinical and Experimental Pharmacology and Physiology, Volume 36, Number 11, November 2009 , pp. 1074-1078(5)

Publisher: Blackwell Publishing

Urokinase plasminogen activator system as a potential target for cancer therapy

Authors: Mekkawy, Ahmed H; Morris, David L; Pourgholami, Mohammad H

Source: Future Oncology, Volume 5, Number 9, November 2009 , pp. 1487-1499(13)

Publisher: Future Medicine

Betulin Elicits Anti-Cancer Effects in Tumour Primary Cultures and Cell Lines In Vitro

Authors: Rzeski, Wojciech; Stepulak, Andrzej; Szymański, Marek; Juszczak, Małgorzata; Grabarska, Aneta; Sifringer, Marco; Kaczor, Józef; Kandefer-Szerszeń, Martyna

Source: Basic & Clinical Pharmacology & Toxicology, Volume 105, Number 6, December 2009 , pp. 425-432(8)

Publisher: Blackwell Publishing

Multifunctional Lipoic Acid Conjugates

Authors: Koufaki, M.; Detsi, A.; Kiziridi, C.

Source: Current Medicinal Chemistry, Volume 16, Number 35, December 2009 , pp. 4728-4742(15)

Publisher: Bentham Science Publishers

Status of Non-Classical Mononuclear Platinum Anticancer Drug Development

Authors: Zhang, Jinchao; Liu, Dandan; Li, Yaping; Sun, Jing; Wang, Liwei; Zang, Aimin

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 11, October 2009 , pp. 1357-1366(10)

Publisher: Bentham Science Publishers

Strategies for Stalling Malignancy: Targeting Cancer's Addiction to Hsp90

Author: Prodromou, Chrisostomos

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 15, November 2009 , pp. 1352-1368(17)

Publisher: Bentham Science Publishers

Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

Authors: Hanauske, A.-R.; Lahn, M.; Musib, L. C.; Weigang-Khler, K.; Yilmaz, E.; Graefe, T.; Kuenen, B.; Thornton, D.; McNealy, P.; Giaccone, G.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1565-1575(11)

Publisher: Oxford University Press

Overview of Naphthalimide Analogs as Anticancer Agents

Authors: Lv, Min; Xu, Hui

Source: Current Medicinal Chemistry, Volume 16, Number 36, December 2009 , pp. 4797-4813(17)

Publisher: Bentham Science Publishers

Editorial [Hot topic: Natural Products (Guest Editors: Wei-Shuo Fang and Junzeng Zhang)]

Authors: Fang, Wei-Shuo; Zhang, Junzeng

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 16, November 2009 , pp. 1493-1493(1)

Publisher: Bentham Science Publishers

Chemical and Biological Explorations of the Family of CC-1065 and the Duocarmycin Natural Products

Authors: Ghosh, Nandita; Sheldrake, Helen M.; Searcey, Mark; Pors, Klaus

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 16, November 2009 , pp. 1494-1524(31)

Publisher: Bentham Science Publishers

Cellular Fingerprints: A Novel Approach Using Large-Scale Cancer Cell Line Data for the Identification of Potential Anticancer Agents

Authors: Füllbeck, Melanie; Dunkel, Mathias; Hossbach, Julia; Daniel, Peter T.; Preissner, Robert

Source: Chemical Biology & Drug Design, Volume 74, Number 5, November 2009 , pp. 439-448(10)

Publisher: Blackwell Publishing

Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma

Authors: Wongkham, Sopit; Junking, Mutita; Wongkham, Chaisiri; Sripa, Banchob; Chur-in, Siri; Araki, Norie

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2077-2084(8)

Publisher: Blackwell Publishing